Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026)
Beam Therapeutics (BEAM) reported Interest & Investment Income of $9.9 million for Q1 2026, little changed year-over-year from $9.9 million in Q1 2025, and down 7.27% on a QoQ basis from $10.6 million in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of Interest & Investment Income data on file, last reported at $9.9 million in Q1 2026.
- Quarterly Interest & Investment Income changed 0.03% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.7 million (down 7.16% YoY) and the FY2025 annual result came in at $43.7 million, down 10.92% from the prior year.
- Interest & Investment Income fell to $9.9 million in Q1 2026 per BEAM's latest filing, from $10.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $14.2 million in Q2 2024 and bottomed at $644000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $10.9 million (2025), against an average of $9.7 million.
- The widest annual swing landed in 2022, when Interest & Investment Income jumped 55255.56%; it then dropped 16.75% in 2025.
- Tracing BEAM's Interest & Investment Income over 5 years: stood at $7.6 million in 2022, then surged by 58.51% to $12.1 million in 2023, then slipped by 9.42% to $10.9 million in 2024, then slipped by 2.64% to $10.6 million in 2025, then retreated by 7.27% to $9.9 million in 2026.
- Per Business Quant, the three latest BEAM Interest & Investment Income figures stand at $9.9 million (Q1 2026), $10.6 million (Q4 2025), and $10.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | 9.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.87 Mn |
| Dec 31, 2025 | 10.64 Mn |
| Sep 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 12.33 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 10.93 Mn |
| Sep 30, 2024 | 12.13 Mn |
| Jun 30, 2024 | 14.19 Mn |
| Mar 31, 2024 | 11.85 Mn |
| Dec 31, 2023 | 12.06 Mn |
| Sep 30, 2023 | 12.70 Mn |
| Jun 30, 2023 | 11.95 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 7.61 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 644,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | -52,000.00 |
| Mar 31, 2021 | -21,000.00 |
| Dec 31, 2020 | 35,000.00 |
| Sep 30, 2020 | 169,000.00 |
| Jun 30, 2020 | 250,000.00 |
| Mar 31, 2020 | 597,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Sep 30, 2019 | 619,000.00 |
| Jun 30, 2019 | 790,000.00 |
| Mar 31, 2019 | 498,000.00 |